Archive for January, 2010
Written by admin on 14 January 2010
If you are a resident of Planet Earth, you are well aware that we have been in a recession. Many economists say that the recession is still alive and well. Others report that they believe it is over or very nearly over. There is definately no area of life which has not been hit by financial woes. A multitude of jobs have been lost. Companies have downsized, or closed. There are types of jobs may not have been affected as strongly by the recession as others? Are there any who have remained unscathed by our world’s economic crisis?
It would seem feasible that one of the first job areas to suffer during a recession would be sales. It stands to reason that when money gets tight, people have to be more selective of the things on which they spend their money. Purchases can be divided loosely into two classifications. There are luxury items and necessities. Luxury items are usually the first to get bumped off the list of pending purchases. Certain clothing purchases, jewelry and vacations would all fall into the luxury category. Food and fuel are two basic necessities of life.
A third necessity for a large majority of humans is medication. Many people literally depend upon their daily medications to stay alive. Pharmaceutical companies comprise of a multi-billion dollar business industry. These companies are working around the clock formulating, testing, improving and producing medications. They employ thousands of people whose job it is to travel around and talk to doctors and pharmacists about new types of prescription drugs, as they become available for market.
These sales representatives are highly trained in the area of sales, but also must have a vast knowledge of the products which they are introducing to the doctors. The sales representative will typically have a few short minutes out of a busy doctor’s day in which to make an impact on him, on behalf of the drug company. They will have to convince the doctor that this is the drug that he should be prescribing for a particular ailment. Doctors will further research the drug before they actually prescribe it, but the sales representative must gain his interest in that drug initially.
I know a person who is employed as a pharmaceutical sales representative. She is able to work from her home most of the time. However, about once a month her company will fly her to one of several other countries to meet with a small group of doctors. At those meetings, it is her job to make presentations, answer any questions the doctors may have, and generally make them comfortable with their relationship with her drug company. Sometimes with potential customers, she must make them aware of all the many reasons why they should associate themselves with her company. Her level of travel accommodations suggests that there is no recession in the pharmaceutical industry.
For as long as there are humans, there will be ailments. That means that there will always be a need for medications, and the companies who produce them. Sadly enough, people will have to forefit other purchases, if necessary, in order to be able to purchase their medications at any price. Therefore, it is a given that pharmaceutical companies will survive and thrive in any economy.
Powered By Rxid.com
Joe Blogger is a leading authority in the field of Pharmaceutical Sales Jobs and Pharmaceutical recruitment and employment matters. Joe Blogger has written numerous informative articles relating to Pharmaceutical Sales jobs.
www.zenopa.com/pharmaceutical_sales_jobs.htmlWP RobotTags: Pharmaceutical Jobs, Pharmaceutical Sales Jobs, Sales Jobs
Posted in Pharmaceutical | No Comments »
Written by admin on 14 January 2010
Drug product manufacturing in pharmaceutical industries is generally controlled by testing products resulting from a process – finished product testing. Another innovative approach is process analytical technology (PAT) analytical testing is performed during the process. This approach allows adjusting product quality in time and final product testing can be avoided. Process understanding is the basis for this innovative process control system.
The principle of PAT is to control the quality of a drug product based on process understanding by in/on/at line process control. US FDA describes the term “Process Analytical Technologies (PAT)” has been used to describe “a system for designing and controlling manufacturing through timely measurements (i.e. during processing) of critical quality and performance attributes for raw and in-process materials and also processes with the goal of ensuring final product quality”.
In recent years, near-infrared spectroscopy has gained growing interest within the pharmaceutical industry for both quality control and process monitoring. Extending with the diffuse reflectance option, pharmaceutical applications of near-infrared spectroscopy offers the nondestructive instrumental analysis even for intact solid samples (for in-process and end-product control) and gives both chemical and physical information in development or production. Nowadays NIR is used in both off-line and on-line applications in different pharmaceutical industrial process control applications. This paper reviews the application of near infrared (NIR) spectroscopy mainly from a pharmaceutical point of view.
The Near-Infrared Region
The electromagnetic (EM) spectrum covers the range from corpuscular gamma rays to radio radiation. Near infrared (NIR), as defined by the International Union of Pure and Applied Chemistry (IUPAC) is the radiation range of the electromagnetic spectrum, extending from 780 â 2500 nm (12800â4000 cm-1). The absorption in the NIR region arises from overtones and combinations of the fundamental mid-infrared bands. Thus in a wider sense, NIR specroscopy deals including wavelengths between 700 – 3000 nm, near the red of the visible spectrum and near the beginning of fundamental infrared stretches of organic compounds.
NIR- PAT Applications
⢠Raw material analysis
⢠API Applications
⢠Drying
⢠Granulation
⢠Blend Uniformity
⢠Content Uniformity
Drawbacks of conventional tests like HPLC:
They require slow sample preparation, slow analysis and are destructive in nature.
What ifs:
1. What if there was a faster method?
2. What if the method was non destructive?
3. What if tablets could be measured in the native solid state?
4. What if this technique could be moved out of QC and be at-line in production environment?
Better yet, why not On-line?
The method is NIR!
Benefits of NIR On-line Tablet Analysis
Powered By Rxid.com
S.Poongothai,M.Pharm.,(Ph.D)
Research Scholar,Bharath University,
Chennai-600073,India.
WP RobotTags: API-Active Pharmaceutical Ingredients, HPLC-High Performance Liquid Chromatography, Near Infra Red Spectroscopy (NIRS), Pat, Process Control, quality control
Posted in Pharmaceutical | No Comments »
Written by admin on 14 January 2010
IntroductionCourtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the anticipated revenue short-fall, with diversification away from pharmaceuticals into other healthcare sectors one avenue under consideration.Scope
Analysis of Big Pharma’s current business model, and the mergers, acquisitions and divestments which have shaped it.
Classification of the human and animal healthcare landscape.
Analysis of ten healthcare sectors using market size, operating margin, and indicative profit potential.
Assessment of the healthcare landscape, with key recommendations for pharma companies looking to make future M&A decisions.
HighlightsThe average operating margin of pharma-focused companies tends to be higher than that of those with a more diversified business model, implying that increasing pharma-focus is the best strategy to drive profit growth.Both the market size and operating margin associated with pharmaceuticals makes it the most rewarding of all ten healthcare sectors under analysis, and suggests that diversification on the part of Big Pharma will tend to end in profit dilution.Patents are key to the high rewards associated with pharmaceuticals, and are also responsible for making the medical device/diagnostics sector the third most attractive sector under analysis, with branding playing a similar role for consumer/over-the-counter health.Reasons to Purchase
Understand how Big Pharma’s business model has evolved, and how this has impacted on operating margin.
Identify the major sectors within the healthcare landscape, and understand how they relate to one-another.
Analyze the attractiveness of each sector as a target to diversify into, based on market size, operating profit, and indicative profit potential.For more information, please visit :http://www.aarkstore.com/reports/Mapping-the-Healthcare-Landscape-Bringing-pharmaceuticals-into-focus-34241.htmlOr email us at press@aarkstore.com or call +919272852585
Powered By Rxid.com
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.
Cheap Logo DesignTags: bringing, focus, Healthcare, landscape, mapping, Pharmaceuticals
Posted in Pharmaceutical | No Comments »
Written by admin on 14 January 2010
Aarkstore announce a new report “Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI” through its vast collection of market research report.
Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROIs
Offshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years. They enable companies to focus on core competencies such as drug discovery or technology development whilst contracting out non-core processes to experts, often at lower costs. As offshore investments begin to mature and provide returns on investment, the opportunity to migrate individual components or whole segments of R&D portfolios will continue to rise.
‘Key Trends in Offshoring Pharmaceutical R&D’ is a report published evaluates the offshore R&D strategies that can reduce development times and improve productivity, with analysis of a variety of strategic partnerships, academic collaborations, and outsourcing opportunities. This report identifies emerging areas of technological and scientific significance across the globe and examines the offshore strategies and investments of the top 20 pharma and biotech companies across Asia, Australia, Central and Eastern Europe, Latin America and the Far East. This report also provides a financial and managerial valuation of leading companies based on their P/E ratio, return on assets (ROA) and return on investment (ROI) and measures company performance against the healthcare industry, pharmaceutical and biotechnology sectors and leading shares of the S&P500.
Key Findings
Companies that have allocated over 60% of their R&D expenditure offshore have displayed greater shareholder return, operating margins, market capital growth and return on assets.
The US currently attracts 53% of total industry R&D spend, however it is forecast that 20% of this expenditure will migrate to Asia Pacific by 2010. Australia, China and Singapore are emerging as key areas for scientific and technological investment.
Leading pharma and biotech companies have undergone major R&D restructuring over the last five years and now adopt a focused, streamlined global approach which is increasingly reliant on offshore strategic partnerships, academic collaboration and outsourcing to establish networks of scientific expertise.
Scientific and technological excellence within emerging economies is a key incentive for offshore investment, enabling companies to enhance innovation and productivity within their R&D programs.
Managerial expertise is a critical factor driving the success of offshore investments, helping leading pharma and healthcare companies to outperform their peers and the S&P 500 index in 2008.
Use this report to…
Assess the offshore R&D strategies of the top 20 pharma and biotech companies with this report’s analysis of offshore investment and deal trends over the last five years.
Discover which geographic regions have the greatest potential for offshore R&D investment by identifying key areas of technological, scientific and academic expertise across Asia Pacific, Australia, Eastern Europe, Latin America, the Middle East and South Africa.
Measure how the offshore strategies of the top 20 pharma and biotech companies have influenced their R&D productivity and efficiency with this report’s financial and managerial performance review, comparative analysis of healthcare/pharma/biotech sectors and S&P500 index assessment.
Identify the key drivers and opportunities for offshore investment with this report’s analysis of major offshoring trends and R&D developments.
Explore issues including…
Shifting focus of R&D strategies. The industry has become more globalized in its R&D approach as part of efforts to improve productivity and efficiency. Networks of offshore partnerships and academic collaborations are now enabling companies to harness external expertise on a project by project basis.
Offshore investment in emerging economies. Companies are increasingly turning to emerging countries to counter the slowing growth of US and European markets. Investing in offshore R&D facilities provides companies with local expertise and a greater understanding of local economies.
Offshore opportunities in tertiary economies. The success of commercial opportunities in emerging markets has expanded the regional scope of investment, with Australia, Israel and Singapore all seen to provide labour arbitrage and access to specialists.
Focused managerial directives are critical. Successful R&D performance is underpinned by a streamlined R&D strategy which is well managed by a team of scientists, technologists and non-scientists which can guide global networks ensuring early go/no go decision making which builds on the core competencies of both internal and external researchers.
Discover…
Which countries are attracting offshore investment?
Which areas of research and technology are attracting offshore investment?
How are the leading pharma and biotech companies changing their R&D programs?
Which major companies and academic institutions have attracted offshore investment?
What factors are driving offshore investment?
What is the financial performance of the leading pharma and biotech companies based on P/E ratio compared to their peers and the S&P500?
Which companies have delivered the best return on assets and return on investment during the last five years?
How will offshore investment influence R&D productivity in the future?
For more information, please visit :http://www.aarkstore.com/reports/Key-Trends-in-Offshoring-Pharmaceutical-R-D-Company-strategies-emerging-markets-and-impact-on-ROI-13950.htmlOr email us at press@aarkstore.com or call +919272852585
Special offer till 31th Dec 2009
Powered By Rxid.com
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.
WP RobotTags: Company., emerging, impact, key, markets, offshoring, Pharmaceutical, r&d, roi, strategies, trends
Posted in Pharmaceutical | No Comments »
Written by admin on 13 January 2010
SummaryThe leading business intelligence provider, has released its latest research, “Direct to Consumer (DTC) Advertising in Pharmaceuticals – Current and Future Market Outlook, Regulatory Landscape and Case Studies.” The research provides key data, information and analysis of the major issues affecting the stakeholders of the direct to consumer (DTC) advertising market in the US and Europe. It discusses the major changes that have been observed after the relaxation of rules over DTC advertising by the FDA in 1997. The report also covers the issues specific to the European market (where branded DTC advertising is banned). The report provides a comprehensive view of some of the best examples of DTC advertising along with analysis covering the reasons for such success. The report also provides a detailed analysis of failed examples along with the most important lessons. It also provides an insight into government regulations in the US and Europe covering DTC advertisements and their implications for the marketing strategies of the pharmaceutical companies. The study provides a detailed explanation of some of the major reasons behind recent developments in the pharmaceutical DTC advertising landscape. At the end, the report touches upon some of the major trends that are likely to shape the future landscape for the DTC advertising market in the US and Europe.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.ScopeThe scope of this report includes: – Identification and analysis of major issues that are affecting the DTC advertising marketplace in the US and Europe- Case studies of DTC advertising strategies of Pfizer, AstraZeneca, Merck and Sanofi-Aventis and so on- Estimation and analysis of potential impact of the issues on the key stakeholders affected by the DTC advertisement market developments- Analysis of key government regulations in the US and Europe affecting the DTC advertising market- Future trends that will shape the DTC advertising market in the US and Europe Reasons to buyThe report will enhance your decision making and will enable you to:- Develop effective business strategies to tackle the impact of major issues to the key stakeholders in the DTC advertising market- Understand the DTC advertising strategies that succeeded and failed for the major drugs of key pharmaceutical players- Ensure success through more effective marketing strategies for the drugs that are to be launched or already in the market- Identify and exploit the factors that could help to maximize returns on drugs through better advertising- Optimize your advertising impact through identification of the most suitable medium for your drug- Develop understanding of the regulatory attitude and hurdles for DTC advertising in the geographies covered in the report.For more information, please visit :http://www.aarkstore.com/reports/Direct-to-Consumer-DTC-Advertising-in-Pharmaceuticals-Current-and-Future-Market-Outlook-Regulatory-Landscape-and-Case-Studies-34393.htmlOr email us at press@aarkstore.com or call +919272852585
Powered By Rxid.com
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.
the cheapest solar panelsTags: Advertising, case, consumer, current, direct, Future, landscape, Market., outlook, Pharmaceuticals, regulatory, studies
Posted in Pharmaceutical | No Comments »
Written by admin on 13 January 2010
In the United States, there is no such thing as pharmaceutical grade fish oil. In some parts of Europe, the supplement is prescribed and there are regulations concerning its potency and purity. But, in the US, we must rely on the manufacturers’ ability to provide a safe supplement.
Laws passed in the 1990s placed the responsibility of providing a safe supplement solely on the manufacturer’s shoulders. If a supplement proves to be unsafe, the Food and Drug Administration will step in and remove the product from the market. But, that’s it.
There are regulations concerning the health claims that can be included on the label. Complaints can be made to either the FDA or the Federal Trade Commission, if a manufacturer makes misleading statements about what a supplement can and cannot do.
Independent evaluations have shown that most brands are safe. Surveys conducted by the Environmental Defense Fund have shown that most manufacturers follow guidelines created by the supplement industry’s watchdog group, “The Council for Responsible Nutrition”. But, there are exceptions.
If there were such a thing as pharmaceutical fish oil in the US, it would be free of mercury and cancer-causing chemicals like PCBs. PCBs were banned in the 1970s, but they are “persistent” in the environment, meaning they are still in our oceans and still in our fish.
Several years ago, Green Peace paid for testing of “Omega Pure” supplements, manufactured by a Houston company called Omega Protein. The organization decided to conduct the tests after watching Omega Protein’s poor fishing practices for several years. They basically vacuum menhaden, a filter fish, out of the delicate Chesapeake Bay, which disrupts the eco-system in many ways.
The testing showed that “Omega Pure” would not qualify as pharmaceutical grade fish oil, because it contains high levels of cancer-causing PCBs and dioxins. That’s not surprising, since the Chesapeake Bay, the rivers that empty into it and the Atlantic Ocean have been damaged by industrial pollution for decades.
So, there are some bad supplements. There are many good ones, too. Consumers can easily identify the best by looking for a manufacturer that displays a copy of an independent laboratory analysis on their websites. They are usually referred to as COAs (Certificates of Analysis).
A COA will list common contaminants like lead and mercury and cancer-causing chemicals like PCBs and dioxins. It will also list the omega-3 content.
If there were such a thing as pharmaceutical fish oil in the US, there would probably be regulations concerning the minimum amount of omega-3s that could be present in order to “pass”. Most capsules contain 1000mg of oils or fat, but only part of that is omega-3 fat. The rest is omega-6 or 9. We get more than enough omega-6s in our diet. That’s why we need an omega-3 supplement in the first place. It helps to counteract the negative effects of omega-6s in the diet.
If you look at the COA and buy a supplement that is certified to provide a minimum of 500mg of omega-3s per capsule, you will be getting the closest thing possible to pharmaceutical grade fish oil. That’s a fact.
Powered By Rxid.com
Lauren Casey is a consumer advocate and a dedicated researcher who has been on a search to find the best nutritional supplements available. After extensive research, she has found an exceptional nutritional supplement that is now a part of the foundation of her own health program. Visit her website at
http://www.omega-3-guides.com to discover what she personally recommends and why.
Tags: pharmaceutical grade fish oil
Posted in Pharmaceutical | No Comments »
Written by admin on 13 January 2010
Have you ever imagined that it was possible for prescription drugs to come out of your kitchen faucet? I know it seems hard to believe, but just how do pharmaceutical drugs get in drinking water when taxpayers support water treatment systems? When a recent probe finds drugs in drinking water, then it’s time to take this question very seriously.
The funny thing about this issue is that scientists didn’t begin studying this problem until it was brought to their attention by an award-winning science project conducted by a West Virginia high school student. This is how this amazing story unfolded:
1. Ashley Mulroy’s student scientific probe finds drugs in drinking water.
2. The EPA and National Geological Survey now want to know how do phramaceutical drugs get into drinking water.
3. Their investigations turn up traces of antibiotics, anti-depressants, birth control drugs and caffeine in numerous water samples taken from across the country.
4. Because this is a relatively new discovery, scientists are unsure about the long-term health effects on humans.
5. Medical experts worry about the development of “super,” disease-causing bugs that may be created from drug-infested water supplies.
6. Municipal, tax supported, water treatment systems are not currently equipped to remove pharmaceutical drugs from water supplies.
The majority of our local water treatment facilities are based upon chlorination. While chlorine is capable of disinfecting certain dangerous bacteria, it can’t filter out synthetic substances like pharmaceuticals. Ironically, just like prescription drugs, chlorine is also a synthetic chemical. With all the water pollution that comes from industrial chemicals, our inadequate water treatment systems desperately need to be updated.
Ok. So now we know that prescription drugs are, in fact, present in our water. But that still doesn’t answer the question, “how do pharmaceutical drugs get in drinking water?” The answer isn’t all that mysterious. The earth’s entire water supply is fixed. This means that this finite supply gets used over and over and over. Water flows down our drains from our sinks, tubs and toilets, into our local water treatment systems, carrying whatever substances that we’ve added from our daily usage…including any drugs that pass through our bodies.
So where does that leave us? Just because a probe finds drugs in drinking water, and our tax supported water treatment systems can’t get rid of them, are we sitting ducks for whatever dangerous effects these substances may or may not produce?
The answer is an emphatic, “NO!” You can safeguard your family’s drinking water from the potential dangers of pharmaceuticals and the majority of chemical toxins by installing an in home water filtration system.
Reverse osmosis and distillation systems can do the job, but you may find them to be expensive and inconvenient options. For my money and time, I have found that home water purification systems that use a multi-stage filtration method are the best at providing a clean, healthy, all-purpose water supply. This means we can drink, cook, bathe and shower, confident in the fact that we’re not being exposed to dangerous chemical contaminants…including chlorine.
If a probe finds drugs in drinking water then I think it begs the question, “how do pharmaceutical drugs get in drinking water when we pay taxes for clean water?” Until it’s possible to get a satisfactory answer, do you and your family a favor. Look into finding the best in home water filtration system.
Powered By Rxid.com
Tags: How Do Pharmaceutical Drugs Get In Drinking Water, Probe Finds Drugs In Drinking Water
Posted in Pharmaceutical | No Comments »
Written by admin on 12 January 2010
I don’t know anything about you, but chances are you would already be aware of the amazing health benefits that pharmaceutical grade fish oil can provide us. Not only does it protect our heart, it also prevents all kinds of cancer, reduces arthritic pain and keeps our brain sharp. However, it can be a little difficult to choose one out of so many available options. Here’s a checklist to make this process easier.
Qualities of a good pharmaceutical grade fish oil:
What kind of fish has it been extracted from? This is the most important factor in evaluating the oil. We need to look for oil containing Omega 3 fatty acids in it. These are the most beneficial kinds of fats that we can get from any food source. The point is, not all kinds of fish contain Omega 3, and an even lesser number have enough DHA Omega 3 fats. Make sure your oil has been extracted from fish rich in DHA Omega 3, like the salmon, mackerel, or even better – the Hoki fish from New Zealand.
Check the DHA and EPA content in the oil DHA and EPA are essential fats that are responsible for all the fish oil benefits. A pharmaceutical fish oil containing high amounts of DHA and EPA is one you should be looking for. In fact, the DHA levels should be at least double of that of EPA.
What about refining? Fish oil can contain contaminants like mercury and lead that the fish absorbs from the polluted ocean water. That’s why it is essential the oil be properly refined to remove all impurities and made fit for human consumption. Molecular Distillation is the process that can do this effectively. Check if your oil has been refined through this process or not.
Is the oil up to industry standards? There is no single set of standards that identifies an oil as pharmaceutical grade fish oil. There is the IFOS (International Fish Oil Standards), Norwegian Medicinal Standard, and many others. In fact, some companies follow their own quality standards that are even stricter than the ones set by these organizations. This kind of product should be your first choice as it would be the safest one you can get. If not that, then aim for an oil that follows the established standards at least.
So, go ahead and find out now a pharmaceutical grade fish oil that does well on the parameters that we have identified here.
Powered By Rxid.com
Visit my website today to learn more about
zone fish oil and other fish oil supplements I’ve discovered that I’d like to share with you.
Michael Holman is a dedicated researcher and reviewer of fish oil supplements. He shares his research on his website – Omega3Information. To discover the highest Omega 3 fish oil supplements our editors personally use and recommend, visit –
http://www.omega3information.comFree WP PluginsTags: pharmaceutical fish oil, pharmaceutical grade fish oil
Posted in Pharmaceutical | No Comments »
Written by admin on 12 January 2010
Traditional pharmaceutical marketing techniques are becoming less effective. With 80% of online consumers searching for health information regularly, there is a growing need for the pharmaceutical industry to develop integrated online strategies. This figure coincides with the rapid growth of direct pharmaceutical sales to consumers which grew from $700 million in 1997 to an incredible $4.2 billion in 2005 (United States Government Accountability Office 2006).
According to the Pew Internet & American Life Project, 113 million Americans – or 37% of the country – use the internet to find health-related information. But Michael Keriakos, co-founder and president of Waterfront Media, estimates that whilst companies in other industries are dedicating around 10% of their budgets to their online strategies, pharmaceutical companies, on average, dedicate less than 2%.
The internet is a medium where pharmaceutical companies can ‘get alongside’ patients and physicians alike, and effective online strategies offers a more complete brand experience. With the web having high usability and accessibility, it has become the largest known audience for any marketing tool and is the fastest way to spread information globally. Not only is it vast, but it can be used to target specific markets making it a personal approach to marketing. It is an invaluable market research tool with the ability to fully record, track and analyse online strategies. Its global research presents the pharmaceutical industry an opportunity to reach emerging markets effectively both in resources and in outcomes.
Developing online strategies not only results in lower costs for the distribution of information and media to a global audience, but its interactivity means you can provide and elicit instant responses to user queries. Whilst online strategiesis often considered to have a broader scope because it incorporates the internet, social media, email and wireless media, it is also targeted using tracking software, statistics and analysis, management of customer data and electronic customer relationship management (ECRM) systems.
http://www.design-logix.co.uk/blog/blog-entry/online_strategies_for_the_pharmaceutical_industry
Powered By Rxid.com
Tags: Online Strategies, Pharmaceutical Industry
Posted in Pharmaceutical | No Comments »
Written by admin on 11 January 2010
How do pharmaceutical drugs get in drinking water?
Have you read about this recently? “Probe finds drugs in drinking water” – this was in the news a few days back.
A number of pharmaceutical drugs can be found in our drinking water. These drugs are very strong chemicals and can cause severe harm to our health. But how do they get in the water in the first place?
To know the answer to the question “how do pharmaceutical drugs get in drinking water?”, we have to take a look at the lifecycle of the drug.
The first stage is the manufacturing process of the drugs. All the chemical wastes of the drug manufacturing units ultimately are disposed of in our water sources like rivers and lakes.
This is the first point where prescription drugs like pain killers, hormone enhancers, and anti depressants get added into our water sources.
Later when this water is used by our water companies for supplying to our homes, they do try to purify it by adding chlorine in it. Now chlorine may be effective at killing the microbes in the water, but it cannot remove any chemicals present in the water like the pharmaceutical drugs.
Another smaller yet significant source of these drugs in the water is – the traces of drugs that our bodies secrete. Any medicines that we take, our body is not able to absorb it 100%. Small traces of the medicine are still left unused and are released from the body by excretion.
These drugs then get added into the sewage and are still present in the water even after it has been cleaned and recycled for re-use.
So what’s the risk from them? These drugs are very strong chemicals, designed for use by people having specific health problems. Any other person taking these drugs can face serious health problems like improper functioning of the organs and potentially life threatening complications.
What to do about these drugs? The best way to get rid of these drugs from your drinking water is to first purify it by a good water filter.
Look for one that can remove all kinds of contaminants from the water – the pharmaceutical drugs, organic impurities, microbes and even heavy metals. A filter with the combined techniques of ion exchange, carbon filtration and sub micron filtration can do this effectively and that too without removing the natural minerals in the water.
Now that you know how do pharmaceutical drugs get in drinking water, take steps now to protect your health from these dangerous chemicals.
Powered By Rxid.com
Tags: How Do Pharmaceutical Drugs Get In Drinking Water, Probe Finds Drugs In Drinking Water
Posted in Pharmaceutical | No Comments »
